A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

This is an open-label, multicenter phase 1 study to evaluate the safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors

Trial Details

NCT ID
NCT06792552
Phase
PHASE1
Sponsor
NextCure, Inc.
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • SIM0505 for injection
Locations (sample)
  • Orlando, Florida, United States|28.53834,-81.37924
  • Atlanta, Georgia, United States|33.749,-84.38798
  • New Orleans, Louisiana, United States|29.95465,-90.07507
  • Boston, Massachusetts, United States|42.35843,-71.05977
  • Hackensack, New Jersey, United States|40.88593,-74.04347

Key Eligibility Criteria

  • Written informed consent is obtained prior to any procedures that are not considered standard of care.
  • ≥18 years of age.
  • In Part 1:
  • Participants with histologically or cytologically confirmed advanced solid tumors, who have failed or are ineligible for standard of care therapies.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →